Shut down the Baltimore-Bayview Drug Substance manufacturing facility
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 1 May 2024
- Due
- 31 Dec 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“As part of the operational changes, Emergent will shut down both its Baltimore-Bayview Drug Substance manufacturing facility and Rockville, Maryland Drug Product facility.”
What we found
Evidence strength A What the grades mean
The company confirmed the closure of the Baltimore-Bayview Drug Substance manufacturing facility as part of its May 2024 organizational restructuring plan.
-
A Emergent BioSolutions Inc. 10-Q filed 2025-05-08
“the sale of our Baltimore-Bayview drug substance manufacturing facility to Syngene International (“Syngene”);” ✓ confirmed on the page
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Facility other
- Indicative materiality
- Medium rules
- Action
- Shut
- Deliverable
- Baltimore-Bayview Drug Substance manufacturing facility
- Where
- Baltimore, Maryland
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Emergent BioSolutions Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-EBS-002490 · Corrections policy